Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
about
Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplicationsMaternal-fetal unit interactions and eutherian neocortical development and evolutionDeficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice.Select cognitive deficits in vasoactive intestinal peptide deficient mice.Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders.Prenatal treatment prevents learning deficit in Down syndrome model.VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerThe effects of vasoactive intestinal peptide in neurodegenerative disorders.Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance.The expression of vasoactive intestinal polypeptide in visual cortex-17 in normal visual development and formation of anisometropic amblyopia.Vasoactive intestinal polypeptide immunoreactivity in the human cerebellum: qualitative and quantitative analyses.
P2860
Q28304430-6CC5BD02-8430-4C39-A1AC-A6A4407F59E2Q28677020-0B2A8645-D2C7-49E7-9F81-815121E21BB3Q30489888-CAEC338E-D21F-4BCD-849B-FE7C79B276EDQ33350694-2BEF81D2-1CA4-4CBD-88D1-B96F38258A07Q34238010-D555DF8F-63FC-41D2-99E1-37A00A89AA2DQ34259060-8F5D4D48-7CE6-406C-A565-9FE6BDCB1B86Q34500663-556E7C4A-EEC9-49F9-AFA6-965CE43F85A6Q34788079-433E9ACA-8703-4906-98B5-766F8583F85FQ36807298-1D573532-EA72-4473-8401-D15FA51A6FFBQ36834005-47525D84-4D2A-422A-A937-EB6A86ABFB60Q38992271-D240A1D7-17CD-4D53-BA48-4A1C0C368DECQ42380034-B2E5EC6A-C294-4943-9FB8-09A55F3D52E1Q44606953-BDE4B016-6817-4015-8AFA-45AD2E3AC6D5Q45919358-A940854A-2CBE-4F14-A239-FEEEE79FDACA
P2860
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@ast
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@en
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@nl
type
label
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@ast
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@en
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@nl
prefLabel
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@ast
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@en
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@nl
P1476
Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.
@en
P2093
Joanna M Hill
P304
P356
10.2174/138161207780618975
P577
2007-01-01T00:00:00Z